Zhang Q Y, Hammerberg C, Baldassare J J, Henderson P A, Burns D, Ceska M, Voorhees J J, Fisher G J
Department of Dermatology, University of Michigan, Ann Arbor 48109.
J Immunol. 1992 Aug 15;149(4):1402-8.
Phorbol ester (TPA) and retinoic acid (RA) are two potent immunomodulatory agents whose actions are mediated through distinct signal transduction pathways involving protein kinase C (PKC) and nuclear RA receptors, respectively. We have investigated the interactions between these two pathways in the regulation of expression of the inflammatory cytokine IL-8 in human skin fibroblasts. TPA (as previously reported) and RA both induced IL-8 mRNA and protein in a time- and dose-dependent manner. IL-8 mRNA induction by TPA (10 nM) was maximal (15-fold) within 6 h, and returned to baseline within 24 h of treatment, although maximal induction (10-fold) by RA (1 microM) did not occur until 24 h posttreatment. Induction of IL-8 by TPA was blocked by 1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine, which inhibits PKC and cAMP-dependent protein kinases (PKA), but not by N-(2-ganidinoethyl)-5-isoquinoline sulfonamide, which preferentially inhibits PKA, consistent with the participation of PKC in the induction of IL-8 by TPA. In contrast, induction of IL-8 by RA was inhibited by both 1-(5-isoquinoline sulfonamide and N-(2-gamidinoethyl)-5-isoquinoline sulfonamide, suggesting the participation of PKA in the induction of IL-8 by RA. However, activation of PKA by addition of cAMP analogues was not sufficient to induce IL-8 expression. Induction of IL-8 by RA also did not appear to be mediated indirectly through induction of IL-1, because addition of IL-1R antagonist did not block IL-8 induction by RA. RA and TPA added in combination synergistically enhanced expression of IL-8 mRNA, measured at 6 (2-fold) and 24 h (10-fold) posttreatment. To investigate the mechanism of this synergy, the effect of TPA and RA on fibroblast PKC activation and PKC isozyme levels were determined. TPA, either alone or together with RA, but not RA alone, stimulated phosphorylation of an endogenous 80-kDa PKC substrate. Dermal fibroblasts expressed three PKC isozymes (alpha, (delta, and (epsilon). TPA, but not RA, down-regulated PKC-alpha, neither TPA or RA affected the level of PKC-delta, and both TPA and RA down-regulated PKC-epsilon. This latter effect was enhanced 2-fold by addition of RA and TPA together. These data suggest that modulation of PKC-epsilon may be a common participant in the regulation of IL-8 expression by TPA and RA.
佛波酯(TPA)和视黄酸(RA)是两种强效免疫调节剂,其作用分别通过涉及蛋白激酶C(PKC)和核视黄酸受体的不同信号转导途径介导。我们研究了这两条途径在人皮肤成纤维细胞中炎症细胞因子IL-8表达调控中的相互作用。TPA(如先前报道)和RA均以时间和剂量依赖性方式诱导IL-8 mRNA和蛋白表达。TPA(10 nM)诱导IL-8 mRNA在6小时内达到最大值(15倍),并在处理后24小时内恢复到基线水平,而RA(1 microM)的最大诱导(10倍)直到处理后24小时才出现。TPA诱导的IL-8被1-(5-异喹啉磺酰基)-2-甲基哌嗪阻断,该物质抑制PKC和cAMP依赖性蛋白激酶(PKA),但不被优先抑制PKA的N-(2-胍基乙基)-5-异喹啉磺酰胺阻断,这与PKC参与TPA诱导IL-8一致。相反,RA诱导的IL-8被1-(5-异喹啉磺酰胺)和N-(2-胍基乙基)-5-异喹啉磺酰胺均抑制,表明PKA参与RA诱导IL-8。然而,添加cAMP类似物激活PKA不足以诱导IL-8表达。RA诱导的IL-8似乎也不是通过诱导IL-1间接介导的,因为添加IL-1R拮抗剂并不能阻断RA诱导的IL-8。联合添加RA和TPA协同增强了处理后6小时(2倍)和24小时(10倍)时IL-8 mRNA的表达。为了研究这种协同作用的机制,测定了TPA和RA对成纤维细胞PKC激活和PKC同工酶水平的影响。TPA单独或与RA一起,但不是单独的RA,刺激了内源性80-kDa PKC底物的磷酸化。真皮成纤维细胞表达三种PKC同工酶(α、δ和ε)。TPA,但不是RA,下调PKC-α,TPA和RA均不影响PKC-δ水平,TPA和RA均下调PKC-ε。添加RA和TPA一起可使后一种作用增强2倍。这些数据表明,PKC-ε的调节可能是TPA和RA调节IL-8表达的共同参与者。